| Literature DB >> 25205116 |
Yiran Guo1, Melissa Kartawinata2, Jiankang Li3, Hilda A Pickett2, Juliana Teo4, Tatjana Kilo4, Pasquale M Barbaro5, Brendan Keating6, Yulan Chen3, Lifeng Tian1, Ahmad Al-Odaib7, Roger R Reddel2, John Christodoulou8, Xun Xu3, Hakon Hakonarson6, Tracy M Bryan2.
Abstract
Telomerase is a ribonucleoprotein enzyme that is necessary for overcoming telomere shortening in human germ and stem cells. Mutations in telomerase or other telomere-maintenance proteins can lead to diseases characterized by depletion of hematopoietic stem cells and bone marrow failure (BMF). Telomerase localization to telomeres requires an interaction with a region on the surface of the telomere-binding protein TPP1 known as the TEL patch. Here, we identify a family with aplastic anemia and other related hematopoietic disorders in which a 1-amino-acid deletion in the TEL patch of TPP1 (ΔK170) segregates with disease. All family members carrying this mutation, but not those with wild-type TPP1, have short telomeres. When introduced into 293T cells, TPP1 with the ΔK170 mutation is able to localize to telomeres but fails to recruit telomerase to telomeres, supporting a causal relationship between this TPP1 mutation and bone marrow disorders. ACD/TPP1 is thus a newly identified telomere-related gene in which mutations cause aplastic anemia and related BMF disorders.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25205116 PMCID: PMC4215308 DOI: 10.1182/blood-2014-08-596445
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 25.476